Skip Nav Destination
Issues
Neuroendocrinology 2019, Vol. 108, No. 4
Original Paper
Clinicopathologic Characteristics and Survival of Patients with Gastroenteropancreatic Neuroendocrine Neoplasm in a Multi-Ethnic Asian Institution
Wai Meng Tai; Sze Huey Tan; Damien Meng Yew Tan; Kelvin Siu Hoong Loke; David Chee Eng Ng; Sean Xuexian Yan; Jacqueline Siok Gek Hwang; Kiat Hon Lim; Lih Ming Loh; Peng Chin Kek; Brian Kim Poh Goh; Ser Yee Lee; Alexander Yaw Fui Chung; Simon Yew Kuang Ong
Neuroendocrinology (2019) 108 (4): 265–277.
https://doi.org/10.1159/000495140
Chronic Stress Combined with a Fructose Diet Reduces Hypothalamic Insulin Signaling and Antioxidative Defense in Female Rats
Neuroendocrinology (2019) 108 (4): 278–290.
https://doi.org/10.1159/000496391
Leukemia Inhibitory Factor Represses GnRH Gene Expression via cFOS during Inflammation in Male Mice
Neuroendocrinology (2019) 108 (4): 291–307.
https://doi.org/10.1159/000496754
Lung Metastases in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Neoplasms: An Appraisal of the Validity of Thoracic Imaging Surveillance
Kosmas Daskalakis; Marina Tsoli; Raj Srirajaskanthan; Eleftherios Chatzellis; Krystallenia Alexandraki; Anna Angelousi; Michail Pizanias; Harpal Randeva; Gregory Kaltsas; Martin O. Weickert
Neuroendocrinology (2019) 108 (4): 308–316.
https://doi.org/10.1159/000497183
Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial)
John K. Ramage; Pankaj Punia; Olusola Faluyi; Andrea Frilling; Tim Meyer; Ruby Saharan; Juan W. Valle
Neuroendocrinology (2019) 108 (4): 317–327.
https://doi.org/10.1159/000497330
Differential CRE Expression in Lhrh-cre and GnRH-cre Alleles and the Impact on Fertility in Otx2-Flox Mice
Hanne M. Hoffmann; Rachel Larder; Jessica S. Lee; Rachael J. Hu; Crystal Trang; Brooke M. Devries; Daniel D. Clark; Pamela L. Mellon
Neuroendocrinology (2019) 108 (4): 328–342.
https://doi.org/10.1159/000497791
Comparison of Temozolomide-Capecitabine to 5-Fluorouracile-Dacarbazine in 247 Patients with Advanced Digestive Neuroendocrine Tumors Using Propensity Score Analyses
Louis de Mestier; Thomas Walter; Hedia Brixi; Camille Evrard; Jean-Louis Legoux; Paul de Boissieu; Olivia Hentic; Jérôme Cros; Pascal Hammel; David Tougeron; Catherine Lombard-Bohas; Vinciane Rebours; Philippe Ruszniewski; Guillaume Cadiot
Neuroendocrinology (2019) 108 (4): 343–353.
https://doi.org/10.1159/000498887
At the Cutting Edge
Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer’s Disease and Melatonin
Neuroendocrinology (2019) 108 (4): 354–364.
https://doi.org/10.1159/000494889
Letter to the Editor
Comment on Sundin et al.: ENETS Consensus Guidelines
Neuroendocrinology (2019) 108 (4): 365.
https://doi.org/10.1159/000497418
Letter to the Editor / Reply
Response to Prof. Ingo Brink and Prof. Aubalewska-Dydejczyk regarding Their “Letter to the Editor”
Neuroendocrinology (2019) 108 (4): 366.
https://doi.org/10.1159/000497419
